Examples of 'a-galactosidase' in a sentence
Meaning of "a-galactosidase"
a-galactosidase (noun): an enzyme that catalyzes the hydrolysis of a galactoside into a monosaccharide and another compound
How to use "a-galactosidase" in a sentence
Basic
Advanced
a-galactosidase
Chromogenic a-galactosidase substrates are commercially available.
Yet another example is that of a-galactosidase.
To confirm the presence of the a-galactosidase gene, hybridization with radiolabelled probe was performed.
The medium contains a chromogenic substrate for a-galactosidase enzyme.
During batch culture a-galactosidase activities were determined for washed cells and growth medium.
It is recited that raffinose is decomposed by a-galactosidase into sucrose and galactose.
The reactive group is preferably selected so as to enable its conjugation to a-galactosidase.
Techniques for determining an activity of a-galactosidase will be known to a skilled person.
The obtained multicopy integrants expressed and secreted the plant protein a-galactosidase.
Surprisingly, the expression level of a-galactosidase was stable during the whole experiment.
Alternatively, the multimeric protein structure comprises more than two a-galactosidase monomers.
An a-galactosidase having the sequence as defined in SEQ.
Further verification of the identity of the isolated a-galactosidase was provided by gel filtration chromatography.
Optionally, the linking moiety is a moiety which is not derived from a part of the a-galactosidase.
Production of guar a-galactosidase in Saccharomyces cerevisiae using multicopy integration.
See also
A pharmaceutical composition may include the above-mentioned protein having the substrate specificity of a-galactosidase.
Production of guar a-galactosidase in Hansenula polymorpha using multicopy integration.
A blood sample was collected at the time of sacrifice to measure a-galactosidase A activity.
In a preferred embodiment, the a-galactosidase A is associated with a a lysosomal storage disorder.
TCR can then be cleaved in the presence of a suitable a-galactosidase to yield sucralose.
Figure 5 shows tissue distribution of a-galactosidase A after intranasal, intravenous and intramuscular administration of plasmid.
Porcine bone specimens are prepared as described in Example 2 including the a-galactosidase treatment.
Most preferably one substrate is for a-galactosidase and the other is a substrate for B-galactosidase.
In one embodiment, absorption enhancement is achieved through utilization of a combination of a-galactosidase and B-mannanase.
Carbon sources used for screening novel a-galactosidase induction from Streptomyces griseoplanus using minimal media.
A-galactosidase A coding sequences are indicated by the darkened boxes.
Other yet undetermined mechanisms not related to a-galactosidase A enzymatic activity may play a role.
A-galactosidase A enzyme assays in these patients reveal a broad range of enzyme levels.
Patients with the renal variant phenotype can also benefit from a-galactosidase A enzyme replacement therapy.
Determination of a-galactosidase activity The method of Schreuder et al.
Fabry disease is caused by a defect in the a-galactosidase A enzyme.
In a specific embodiment said a-galactosidase A is obtainable by the method described above.
This plasmid was digested with Bam HI to release the a-galactosidase cDNA.
There was a modest increase in a-galactosidase A activity at the lower dose.
A-galactosidase A non-coding genomic sequences are indicated by the lightly filled boxes.
The ELISA was used to detect levels of a-galactosidase A activity in various organs.
Background of the Invention This invention relates to the purification of a-galactosidase A.
Isolating enzymatically active a-galactosidase A enzyme from the mammalian cell culture.
There are several atypical variant phenotypes associated with a-galactosidase A deficiency.
Also described is the expression of a-galactosidase A fusion proteins which are readily purified.
The adenovirus E1a promoter was used to drive expression of the human a-galactosidase A cDNA.
Tissue homogenates were analyzed for a-galactosidase A expression using the ELISA.
Liposome according to claim 9 wherein the therapeutic agent is a-galactosidase.
In some embodiments, the a-galactosidase is an acid a-galactosidase.
Two enzyme replacement therapies ( ERTs ) are available to functionally compensate for a-galactosidase deficiency.
In some embodiments, the a-galactosidase is a plant recombinant a-galactosidase.
According to a specific embodiment, the alkaline a-galactosidase is from melon.
The linking of a-galactosidase monomers by a linking moiety is referred to herein as " cross-linking ".
An ELISA was used to detect levels of a-galactosidase A in various organs.
As used herein, the following terms and abbreviations will have the indicated meaning, a-Galactosidase A.
